Refine by
Biomarker Discovery Articles & Analysis
43 news found
In drug development, it is used to verify the N-terminal sequences of therapeutic proteins, ensuring proper folding and functionality. In biomarker discovery, it helps characterize N-terminal modifications that may serve as disease markers. ...
By leveraging its expertise and resources, the company can develop animal models, cell models, multicellular models, pharmacokinetic/pharmacodynamic modeling, biomarker discovery, and more. These model development services are designed to offer researchers the tools and resources they need to optimize drug development and maximize success rates. ...
This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational modification, significantly impacts protein folding, stability, and activity. ...
These microarrays allow researchers to conduct efficient and cost-effective studies on various neurological conditions, accelerating discoveries with the potential to improve patient outcomes. In addition, CD BioSciences is continually expanding its portfolio to provide scientists with more efficient tools to analyze multiple nervous system tissue samples simultaneously, ...
This analysis facilitates the comparison of exosomal RNA profiles between different conditions or sample types, providing valuable insights into disease mechanisms, biomarker discovery, and treatment response. Comprehensive Annotation and Functional Analysis: CD Genomics offers comprehensive annotation and functional analysis of exosomal RNA data. ...
The product manager is pleased to announce the launch of its Microbial Biomarker Discovery service, a revolutionary solution that promises to transform microbiology research. ...
The company plans to continue growing its team to power the expansion of Juvena’s drug discovery platform and advance the company’s biologics pipeline targeting chronic and age-related diseases. ...
Based on rich experience in genomic analysis, CD Genomics has developed a specialized platform for targeted sequencing of cancer-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. The company has optimized its Cancer Hotspot Panel Sequencing service to meet the most ...
NeuroPointDX, a business unit of Stemina Biomarker Discovery, today announced the company will present recent data from the Children’s Autism Metabolome Project (CAMP), its large, comprehensive clinical study, supporting its precision medicine approach to the diagnosis and treatment of autism spectrum disorder (ASD) at the National TACA Autism Conference. ...
“Exosomes are a rapidly growing research area for biomarker discovery and the diagnosis and treatment of cancer and other ...
“MOBILion’s SLIM platform technology is truly unique, and I look forward to working with the team to support the development of their product roadmap, and ultimately launching impactful products within the biopharma, biomarker discovery, and clinical diagnostics markets.” “This is a great step forward for MOBILion as we evolve from being ...
It allows you to detect splice junctions and significant changes in gene expression for low abundant transcripts, as well as discovery of biomarkers and transcription-factors. “CD Genomics offers a simple, low-cost, and low-bias ultralow input RNA-seq with Illumina sequencing. ...
Joint research of biomarkers on platform technology of GI Innovation, GI-SMART™, and SpAC9 Pipeline, AI-powered biomarker discovery platform of CellKey Prediction of drug response on next-generation immuno-oncology, personalized cancer treatment effects… increasing reliability and efficiency of treatment GI Innovation, an ...
Joint research of biomarkers on platform technology of GI Innovation, GI-SMARTTM and SpAC9 Pipeline, AI-powered biomarker discovery platform of CellKey Prediction of drug response on next generation immuno-oncology, personalized cancer treatment effects… increasing Reliability and efficiency of treatment GI Innovation, a new ...
Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment. ...
CD Genomics uses a variety of Illumina next-generation sequencing platforms to fulfill your various research needs. " "Our sequencing technologies intend to assist basic research and microbiology-based innovation, including Biomarker Discovery, Drug Discovery and Development, Microbial Innovations, and Personalized Medicine. ...
JADBio is a robust Automated Machine Learning platform that allows intuitive, timely, and interactive creation of ML predictive models on BioMedical and Multi-omics data, while allowing for knowledge (biomarker signature) discovery through its vast range of reporting and analysis. ...
ByJADBio
MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of ...
Since lipidomics profiles are of great importance for studying developmental or pathological processes in tissue sections, MALDI-Imaging can serve as a useful tool for biomarker discovery. In lipidomics research, MALDI imaging mass spectrometry (MALDI-IMS) is a powerful tool for studying lipid distribution in tissues. ...
The SMRT-based transcriptomics platform provides a simple and accurate method for various applications, such as gene annotation, identification of transcript isoforms and fusion transcripts, long non-coding RNA (lncRNA) discovery, microRNA (miRNA) discovery, and prediction of potential mRNA target molecules. ...